白云山(00874)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

00874 白云山

交易中 04-23 14:24:44

20.600

+0.050

+0.24%

最高20.600	最低20.250	成交量73.80万
今开20.550	昨收20.550	日振幅1.70%
总市值334.91亿	流通市值45.30亿	总股本16.26亿
成交额1,512万	换手率0.34%	流通股本2.20亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"00874","market":"HK","secType":"STK","nameCN":"白云山","latestPrice":20.6,"timestamp":1713853457494,"preClose":20.55,"halted":0,"volume":738000,"delay":0,"floatShares":219900000,"shares":1625790949,"eps":2.6936312,"marketStatus":"交易中","marketStatusCode":2,"change":0.05,"latestTime":"04-23 14:24:44","open":20.55,"high":20.6,"low":20.25,"amount":15115594,"amplitude":0.017032,"askPrice":20.65,"askSize":16000,"bidPrice":20.6,"bidSize":20000,"shortable":3,"etf":0,"ttmEps":2.6936311393777914,"exchange":"SEHK","tradingStatus":2,"nextMarketStatus":{"tag":"收盘","tradingStatus":0,"beginTime":1713859800000},"adr":0,"adjPreClose":20.55,"dividendRate":0.039287,"openAndCloseTimeList":[[1713835800000,1713844800000],[1713848400000,1713859200000]],"volumeRatio":0.908756,"lotSize":2000,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"600332","market":"SH","secType":"STK","nameCN":"白云山","latestPrice":31.32,"timestamp":1713853478000,"preClose":31.55,"halted":0,"volume":8423377,"delay":0,"premium":"-39.09"}},"requestUrl":"/m/hq/s/00874","defaultTab":"news","newsList":[{"id":"2429949729","title":"白云山：头孢克肟片已通过仿制药质量和疗效一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2429949729","media":"新京报","top":-1,"share":"https://www.laohu8.com/m/news/2429949729?lang=zh_cn&edition=full","pubTime":"2024-04-22 18:43","pubTimestamp":1713782606,"startTime":"0","endTime":"0","summary":"4月22日，白云山公告，分公司广州白云山医药集团股份有限公司白云山制药总厂收到国家药品监督管理局签发的《药品补充申请批件通知书》，头孢克肟片已通过仿制药质量和疗效一致性评价。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202404223054455362.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202404223054455362.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429948760","title":"白云山最新公告：头孢克肟片通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2429948760","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2429948760?lang=zh_cn&edition=full","pubTime":"2024-04-22 17:30","pubTimestamp":1713778212,"startTime":"0","endTime":"0","summary":"白云山公告，公司分公司白云山制药总厂收到国家药监局签发的药品补充申请批件通知书，头孢克肟片通过仿制药质量和疗效一致性评价。头孢克肟为第三代头孢菌素类抗生素，适用于对头孢克肟敏感的链球菌属(肠球菌除外)，肺炎球菌、淋球菌等引起的部分细菌感染性疾病。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024042200020621.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2429091005","title":"白云山(00874.HK)分公司药物通过国家药监局仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2429091005","media":"阿斯达克财经","top":-1,"share":"https://www.laohu8.com/m/news/2429091005?lang=zh_cn&edition=full","pubTime":"2024-04-22 17:13","pubTimestamp":1713777180,"startTime":"0","endTime":"0","summary":"白云山(00874.HK) (600332.SH) 公布，分公司白云山制药总厂，接获国家药品监督管理局签发的《药品补充申请批件通知书》指，Cefixime已通过仿制药质量及疗效一致性评价。相关药物为第三代头孢菌素类抗生素，并适用于对Cefixime敏感的链球菌属(肠球菌除外)、肺炎球菌、淋球菌等引起的细菌感染性疾病。公司披露，白云山制药总厂针对该药品一致性评价，已投入的未审计研发费用约1,664.04万元人民币。(js/da)(港股报价延迟最少十五分钟。沽空资料截至 2024-04-22 16:25。) (A股报价延迟最少十五分钟。)AASTOCKS新闻","market":"fut","thumbnail":"http://plib.aastocks.com/aafnnews/image/medialib/20200312162542031_s.jpg","type":0,"news_type":0,"thumbnails":["http://plib.aastocks.com/aafnnews/image/medialib/20200312162542031_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1344009/latest-news/AAFN","is_publish_highlight":false,"gpt_icon":0},{"id":"2429925910","title":"白云山(00874.HK)：，头孢克肟片通过仿制药一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2429925910","media":"格隆汇资讯","top":-1,"share":"https://www.laohu8.com/m/news/2429925910?lang=zh_cn&edition=full","pubTime":"2024-04-22 17:11","pubTimestamp":1713777100,"startTime":"0","endTime":"0","summary":"格隆汇4月22日丨白云山(00874.HK)发布公告，近日，公司分公司广州白云山医药集团股份有限公司白云山制药总厂(简称“白云山制药总厂”)收到国家药品监督管理局签发的《药品补充申请批件通知书》，头孢克肟片已通过仿制药质量和疗效一致性评价。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404221712228b4586ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404221712228b4586ba&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429891725","title":"白云山(600332.SH)：头孢克肟片通过仿制药质量和疗效一致性评价","url":"https://stock-news.laohu8.com/highlight/detail?id=2429891725","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2429891725?lang=zh_cn&edition=full","pubTime":"2024-04-22 17:05","pubTimestamp":1713776756,"startTime":"0","endTime":"0","summary":"智通财经APP讯，白云山 发布公告，近日，该公司分公司广州白云山医药集团股份有限公司白云山制药总厂收到国家药品监督管理局签发的《药品补充申请批件通知书》，头孢克肟片已通过仿制药质量和疗效一致性评价。白云山制药总厂头孢克肟片于1995年9月在国内正式上市，并于2023年1月5日向国家药品监督管理局递交一致性评价申请，于2023年2月13日获得受理。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1106545.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2429964232","title":"青蒿素概念盘中拉升，白云山涨1.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429964232","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429964232?lang=zh_cn&edition=full","pubTime":"2024-04-22 10:01","pubTimestamp":1713751314,"startTime":"0","endTime":"0","summary":"04月22日，青蒿素概念盘中拉升，截至10点01分，青蒿素概念整体指数上涨0.60%，报1071.870点。从个股上来看，该概念的成分股中，白云山涨1.33%，复星医药、海正药业、浙江医药涨幅居前。从资金上来看，截止发稿，青蒿素概念主力净流入为-3823.69万，其中华润双鹤受到资金热捧，主力净流入515.86万；拉长时间线来看，该板块近20日主力资金净流入-4.07亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240422100154792223b2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240422100154792223b2&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2429041969","title":"超级真菌概念盘中拉升，白云山涨1.65%","url":"https://stock-news.laohu8.com/highlight/detail?id=2429041969","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2429041969?lang=zh_cn&edition=full","pubTime":"2024-04-22 09:48","pubTimestamp":1713750482,"startTime":"0","endTime":"0","summary":"04月22日，超级真菌概念盘中拉升，截至09点47分，超级真菌概念整体指数上涨0.50%，报724.650点。从个股上来看，该概念的成分股中，白云山涨1.65%，重药控股、普洛药业、上海凯宝涨幅居前。从资金上来看，截止发稿，超级真菌概念主力净流入为-663.23万，其中重药控股受到资金热捧，主力净流入782.29万；拉长时间线来看，该板块近20日主力资金净流入-14.99亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240422094802861e7a61&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240422094802861e7a61&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428397096","title":"白云山：2023年度可供分派储备为人民币8,389,265千元","url":"https://stock-news.laohu8.com/highlight/detail?id=2428397096","media":"金融界港股","top":-1,"share":"https://www.laohu8.com/m/news/2428397096?lang=zh_cn&edition=full","pubTime":"2024-04-19 17:26","pubTimestamp":1713518800,"startTime":"0","endTime":"0","summary":"金融界4月19日消息，白云山在2023年年度报告中披露，截至2023年12月31日，公司按照中国企业会计准则计算的可供分派储备为人民币8,389,265千元。\n\n\r\n            责任编辑：十八","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/04/19172640326541.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2428579822","title":"南向资金4月18日净买入白云山33.60万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2428579822","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428579822?lang=zh_cn&edition=full","pubTime":"2024-04-19 09:31","pubTimestamp":1713490283,"startTime":"0","endTime":"0","summary":"4月18日, 南向资金增持白云山33.60万股，连续3日增持。截止当日收盘，港股通共持有白云山10022.13万股，占流通股45.57%。港股通增持金额前五个股分别为腾讯控股、中国石油股份、中国银行、中国移动、建设银行。白云山近5个交易日上涨3.17%，港股通累计增持95.60万股；近20个交易日下跌1.46%，港股通累计增持396.60万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404190941208792bcc8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404190941208792bcc8&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428589728","title":"新“国九条”下，中药板块分红实力凸显，资金重手布局！规模最大中药ETF(560080)连续2日吸金近4000万元！云南白药、白云山、东阿阿胶冲高","url":"https://stock-news.laohu8.com/highlight/detail?id=2428589728","media":"和讯网","top":-1,"share":"https://www.laohu8.com/m/news/2428589728?lang=zh_cn&edition=full","pubTime":"2024-04-18 10:24","pubTimestamp":1713407067,"startTime":"0","endTime":"0","summary":"拉长时间看，截至2024年4月17日，中药ETF近1周累计上涨2.71%。规模方面，中药ETF近1周规模增长7044.68万元，实现显著增长，新增规模位居可比基金1/4。资金流入方面，中药ETF连续2日吸金近4000万元！中药ETF前一交易日融资净买额达172.44万元，最新融资余额达2607.55万元。云南白药2023年底货币资金142.18亿元，预计分红总额37.06亿元，占2023年归母净利润比例90.53%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404181040268b32b18f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404181040268b32b18f&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428944583","title":"禽流感概念盘中拉升，白云山涨1.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2428944583","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428944583?lang=zh_cn&edition=full","pubTime":"2024-04-18 09:58","pubTimestamp":1713405499,"startTime":"0","endTime":"0","summary":"04月18日，禽流感概念盘中拉升，截至09点58分，禽流感概念整体指数上涨0.61%，报1128.550点。从个股上来看，该概念的成分股中，白云山涨1.42%，硕世生物、华润三九、众生药业涨幅居前。从资金上来看，截止发稿，禽流感概念主力净流入为-1357.64万，其中众生药业受到资金热捧，主力净流入546.72万；拉长时间线来看，该板块近20日主力资金净流入-20.70亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404180958197921611e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404180958197921611e&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428306573","title":"智通港股早知道 | 华为Pura70现货已到 3月中国境内外金价溢价回落","url":"https://stock-news.laohu8.com/highlight/detail?id=2428306573","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2428306573?lang=zh_cn&edition=full","pubTime":"2024-04-18 07:45","pubTimestamp":1713397528,"startTime":"0","endTime":"0","summary":"华为Pura70现货已到！经销商打款备货 门店盲订可选三款机型据IT时报，华为Pura 70第一批现货已到总代，部分经销商也已完成打款，等待华为打响开售“发令枪”。“Pura 70已经到货，就等华为通知了，其它消息一概不能透露。”第三方机构对华为Pura70系列的销量比较乐观。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1104311.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2428390098","title":"白云山：4月17日召开董事会会议","url":"https://stock-news.laohu8.com/highlight/detail?id=2428390098","media":"每日经济新闻","top":-1,"share":"https://www.laohu8.com/m/news/2428390098?lang=zh_cn&edition=full","pubTime":"2024-04-17 18:05","pubTimestamp":1713348309,"startTime":"0","endTime":"0","summary":"白云山（SH600332，收盘价：30.33元）4月17日晚间发布公告称，公司第九届第九次董事会会议于2024年4月17日以通讯形式召开。审议了《关于召开2024年第一次A股类别股东大会和2024年第一次H股类别股东大会的议案》等。2023年1至12月份，白云山的营业收入构成为：大商业占比69.87%，大健康占比14.72%，大南药占比14.42%，其他占比0.67%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202404173048919055.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202404173048919055.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2428239731","title":"白云山：分公司收到化学原料药上市申请批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2428239731","media":"市场资讯","top":-1,"share":"https://www.laohu8.com/m/news/2428239731?lang=zh_cn&edition=full","pubTime":"2024-04-17 17:54","pubTimestamp":1713347699,"startTime":"0","endTime":"0","summary":"白云山公告，于2024年4月16日收到国家药品监督管理局核准签发的枸橼酸西地那非化学原料药上市申请批准通知书。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"highlight_sina","url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-04-17/doc-inascsvw8570639.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}","selectors":".art_box, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action, .fl_popup, .weibo_info","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2024-04-17/doc-inascsvw8570639.shtml","is_publish_highlight":false,"gpt_icon":0},{"id":"2428397801","title":"白云山最新公告：枸橼酸西地那非化学原料药上市申请获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2428397801","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2428397801?lang=zh_cn&edition=full","pubTime":"2024-04-17 17:50","pubTimestamp":1713347415,"startTime":"0","endTime":"0","summary":"白云山公告，分公司收到枸橼酸西地那非化学原料药上市申请批准通知书。以上内容由证券之星根据公开信息整理，由算法生成（网信算备310104345710301240019号），与本站立场无关，如数据存在问题请联系我们。本文为数据整理，不对您构成任何投资建议，投资有风险，请谨慎决策。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404171751218b2e5307&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404171751218b2e5307&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2428397858","title":"白云山(600332.SH)获得枸橼酸西地那非化学原料药上市申请批准通知书","url":"https://stock-news.laohu8.com/highlight/detail?id=2428397858","media":"智通财经","top":-1,"share":"https://www.laohu8.com/m/news/2428397858?lang=zh_cn&edition=full","pubTime":"2024-04-17 17:49","pubTimestamp":1713347362,"startTime":"0","endTime":"0","summary":"智通财经APP讯，白云山(600332.SH)发布公告，公司分公司广州白云山医药集团股份有限公司白云山化学制药厂(简称“白云山化学制药厂”)于2024年4月16日收到国家药品监督管理局核准签发的枸橼酸西地那非化学原料药上市申请批准通知书。据悉，枸橼酸西地那非主要适用于治疗性勃起功能障碍。白云山化学制药厂于2014年获得枸橼酸西地那非原料药的生产批文(国药准字H20143277，登记号Y20190009908)。本品为白云山化学制药厂采用新的生产工艺制备的枸橼酸西地那非，完成相关研究、提升质量标准后在2022年8月按照不同登记号向国家食品药品监督管理局进行登记并获得受理。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1103934.html","is_publish_highlight":false,"gpt_icon":0},{"id":"2428313273","title":"北向资金4月16日净买入白云山77.38万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2428313273","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2428313273?lang=zh_cn&edition=full","pubTime":"2024-04-17 09:30","pubTimestamp":1713317411,"startTime":"0","endTime":"0","summary":"4月16日, 北向资金增持白云山77.38万股，连续3日增持。截止当日收盘，沪股通共持有白云山3195.54万股，占流通股2.27%。沪股通增持金额前五个股分别为贵州茅台、三一重工、中国船舶、赤峰黄金、山东黄金。白云山近5个交易日上涨3.32%，沪股通累计增持139.96万股；近20个交易日下跌1.03%，沪股通累计增持88.13万股。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404170931338b2ca0ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404170931338b2ca0ea&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427623888","title":"保健品概念盘中拉升，白云山涨1.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2427623888","media":"自选股智能写手","top":-1,"share":"https://www.laohu8.com/m/news/2427623888?lang=zh_cn&edition=full","pubTime":"2024-04-16 10:57","pubTimestamp":1713236255,"startTime":"0","endTime":"0","summary":"04月16日，保健品概念盘中拉升，截至10点57分，保健品概念整体指数上涨0.50%，报894.350点。从个股上来看，该概念的成分股中，白云山涨1.53%，东阿阿胶、江中药业、汤臣倍健涨幅居前。从资金上来看，截止发稿，保健品概念概念主力净流入为-1.24亿，其中上海医药受到资金热捧，主力净流入1779.99万；拉长时间线来看，该板块近20日主力资金净流入-25.56亿。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161057357920cc22&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202404161057357920cc22&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2427137856","title":"白云山获北向资金买入1606.35万元，累计持股3118.15万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2427137856","media":"金融界","top":-1,"share":"https://www.laohu8.com/m/news/2427137856?lang=zh_cn&edition=full","pubTime":"2024-04-16 08:11","pubTimestamp":1713226301,"startTime":"0","endTime":"0","summary":"4月16日，巨灵财经数据显示，北向资金15日增持白云山预估1606.35万元，累计持股3118.15万股，总计持有市值9.16亿元，占流通股比例2.22%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041608114687819b66&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024041608114687819b66&s=b","is_publish_highlight":false,"gpt_icon":0},{"id":"2426200725","title":"白云山：\n本公司属下各企业均独立经营及财务独立核算","url":"https://stock-news.laohu8.com/highlight/detail?id=2426200725","media":"证券之星","top":-1,"share":"https://www.laohu8.com/m/news/2426200725?lang=zh_cn&edition=full","pubTime":"2024-04-12 19:01","pubTimestamp":1712919682,"startTime":"0","endTime":"0","summary":"证券之星消息，白云山04月12日在投资者关系平台上答复投资者关心的问题。本公司属下各企业均独立经营及财务独立核算。公司已进行资金统筹安排，继续积极提升资金利用率。公司2023年年度报告内其他流动资产中未交增值税借方余额主要是增值税待抵扣进项税金、增值税留抵税额。希望公司采取措施白云山董秘：感谢您的关注和建议。公司重视市值管理工作，将继续推进相关工作。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024041200037253.shtml","is_publish_highlight":false,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.gybys.com.cn","stockEarnings":[{"period":"1week","weight":0.0474},{"period":"1month","weight":0.0485},{"period":"3month","weight":0.0549},{"period":"6month","weight":0.0074},{"period":"1year","weight":-0.1768},{"period":"ytd","weight":-0.0552}],"compareEarnings":[{"period":"1week","weight":-0.0053},{"period":"1month","weight":0.0007},{"period":"3month","weight":0.0754},{"period":"6month","weight":-0.0336},{"period":"1year","weight":-0.1775},{"period":"ytd","weight":-0.0314}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"广州白云山医药集团股份有限公司从事制药和保健行业。该公司的业务分部包括：大南药分部、大健康分部、大商业分部和大医疗分部。大南药分部从事研究、开发、制造和销售中西成药、化学原料药、天然药物、生物医药和化学原料药中间体业务。大健康分部从事研究、开发、制造和销售大健康产品业务。大商业分部从事批发、零售和进出口西药、中药和医疗器械业务。该公司拥有从原料药到制剂的完整抗生素生产链，产品涵盖抗生素常用品种。该公司也研发和生产饮料、食品及其他产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.423077,"avgChangeRate":-0.011838},{"month":2,"riseRate":0.692308,"avgChangeRate":0.06192},{"month":3,"riseRate":0.62963,"avgChangeRate":0.059522},{"month":4,"riseRate":0.666667,"avgChangeRate":0.087372},{"month":5,"riseRate":0.538462,"avgChangeRate":0.048933},{"month":6,"riseRate":0.5,"avgChangeRate":0.023547},{"month":7,"riseRate":0.423077,"avgChangeRate":-0.017589},{"month":8,"riseRate":0.384615,"avgChangeRate":-0.039641},{"month":9,"riseRate":0.384615,"avgChangeRate":-0.014086},{"month":10,"riseRate":0.423077,"avgChangeRate":0.006689},{"month":11,"riseRate":0.444444,"avgChangeRate":0.009177},{"month":12,"riseRate":0.538462,"avgChangeRate":0.0275}],"exchange":"SEHK","name":"白云山","nameEN":"BAIYUNSHAN PH"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.22.4","shortVersion":"4.22.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"白云山(00874)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供白云山(00874)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"白云山,00874,白云山股票,白云山股票老虎,白云山股票老虎国际,白云山行情,白云山股票行情,白云山股价,白云山股市,白云山股票价格,白云山股票交易,白云山股票购买,白云山股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"白云山(00874)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供白云山(00874)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}